Format

Send to

Choose Destination
Circulation. 2018 Apr 24;137(17):1814-1823. doi: 10.1161/CIRCULATIONAHA.117.031622. Epub 2018 Jan 19.

Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.

Author information

1
Division of Cardiology (A.P., W.O., C.A., J.D.B.).
2
Department of Clinical Sciences (C.A., J.D.B.).
3
University of Texas Southwestern Medical Center, Dallas. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University of Buffalo, NY (M.L.).
4
Division of Cardiology, University of California San Francisco (L.K.).
5
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (N.B.A., P.G., D.M.L.-J.).
6
Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, PA (L.H.K.).
7
Department of Epidemiology, School of Public Health and Department of Family Medicine, Alpert Medical School, Brown University, Providence, RI (C.B.E.).
8
Division of Cardiology, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore (J.S.G.).
9
Division of Cardiology (A.P., W.O., C.A., J.D.B.) jarett.berry@utsouthwestern.edu.

Abstract

BACKGROUND:

Lifetime risk of heart failure has been estimated to range from 20% to 46% in diverse sex and race groups. However, lifetime risk estimates for the 2 HF phenotypes, HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF), are not known.

METHODS:

Participant-level data from 2 large prospective cohort studies, the CHS (Cardiovascular Health Study) and MESA (Multiethnic Study of Atherosclerosis), were pooled, excluding individuals with prevalent HF at baseline. Remaining lifetime risk estimates for HFpEF (EF ≥45%) and HFrEF (EF <45%) were determined at different index ages with the use of a modified Kaplan-Meier method with mortality and the other HF subtype as competing risks.

RESULTS:

We included 12 417 participants >45 years of age (22.2% blacks, 44.8% men) who were followed up for median duration of 11.6 years with 2178 overall incident HF events with 561 HFrEF events and 726 HFpEF events. At the index age of 45 years, the lifetime risk for any HF through 90 years of age was higher in men than women (27.4% versus 23.8%). Among HF subtypes, the lifetime risk for HFrEF was higher in men than women (10.6% versus 5.8%). In contrast, the lifetime risk for HFpEF was similar in men and women. In race-stratified analyses, lifetime risk for overall HF was higher in nonblacks than blacks (25.9% versus 22.4%). Among HF subtypes, the lifetime risk for HFpEF was higher in nonblacks than blacks (11.2% versus 7.7%), whereas that for HFrEF was similar across the 2 groups. Among participants with antecedent myocardial infarction before HF diagnosis, the remaining lifetime risks for HFpEF and HFrEF were up to 2.5-fold and 4-fold higher, respectively, compared with those without antecedent myocardial infarction.

CONCLUSIONS:

Lifetime risks for HFpEF and HFrEF vary by sex, race, and history of antecedent myocardial infarction. These insights into the distribution of HF risk and its subtypes could inform the development of targeted strategies to improve population-level HF prevention and control.

KEYWORDS:

heart failure; risk

PMID:
29352072
PMCID:
PMC6417883
DOI:
10.1161/CIRCULATIONAHA.117.031622
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Grant support

Publication types

MeSH terms

Grant support

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center